1. Home
  2. SCLX vs REKR Comparison

SCLX vs REKR Comparison

Compare SCLX & REKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$17.70

Market Cap

139.3M

Sector

Health Care

ML Signal

HOLD

Logo Rekor Systems Inc.

REKR

Rekor Systems Inc.

HOLD

Current Price

$1.86

Market Cap

151.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
REKR
Founded
2011
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
139.3M
151.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLX
REKR
Price
$17.70
$1.86
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
119.6K
3.1M
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,360,000.00
$49,028,000.00
Revenue This Year
N/A
$11.82
Revenue Next Year
$749.70
$22.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.89
52 Week Low
$3.60
$0.62
52 Week High
$34.27
$3.42

Technical Indicators

Market Signals
Indicator
SCLX
REKR
Relative Strength Index (RSI) 44.92 45.53
Support Level $18.34 $1.79
Resistance Level $20.62 $1.80
Average True Range (ATR) 2.14 0.12
MACD -0.28 0.02
Stochastic Oscillator 1.86 63.89

Price Performance

Historical Comparison
SCLX
REKR

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About REKR Rekor Systems Inc.

Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which a majority of its revenue comes from the United States.

Share on Social Networks: